These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15953258)

  • 21. Optimal sample allocation in clinical trials designed to investigate relative risks.
    Eastwood BJ
    Stat Med; 1996 Dec; 15(23):2523-38. PubMed ID: 8961461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic balancing randomization in controlled clinical trials.
    Heritier S; Gebski V; Pillai A
    Stat Med; 2005 Dec; 24(24):3729-41. PubMed ID: 16320277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IRINI: random group allocation of multiple prognostic factors.
    Kasturi J; Geisler JG; Liu J; Kirchner T; Amaratunga D; Lubomirski M
    Contemp Clin Trials; 2011 May; 32(3):372-81. PubMed ID: 21187163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cluster randomized controlled trials in primary care: an introduction.
    Murphy AW; Esterman A; Pilotto LS
    Eur J Gen Pract; 2006; 12(2):70-3. PubMed ID: 16945880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "best balance" allocation led to optimal balance in cluster-controlled trials.
    de Hoop E; Teerenstra S; van Gaal BG; Moerbeek M; Borm GF
    J Clin Epidemiol; 2012 Feb; 65(2):132-7. PubMed ID: 21840173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification methods were developed for selection bias by predictability of allocations with unequal block randomization.
    Dupin-Spriet T; Fermanian J; Spriet A
    J Clin Epidemiol; 2005 Dec; 58(12):1269-76. PubMed ID: 16291471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinding protocols, treatment credibility, and expectancy: methodologic issues in clinical trials of osteopathic manipulative treatment.
    Licciardone JC; Russo DP
    J Am Osteopath Assoc; 2006 Aug; 106(8):457-63. PubMed ID: 16943515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative clinical trials].
    Yokoyama M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some practical problems in implementing randomization.
    Downs M; Tucker K; Christ-Schmidt H; Wittes J
    Clin Trials; 2010 Jun; 7(3):235-45. PubMed ID: 20484491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing for cancer clinical trials: selection of prognostic factors.
    Brown BW
    Cancer Treat Rep; 1980; 64(2-3):499-502. PubMed ID: 7407790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral headache research: methodologic considerations and research design alternatives.
    Hursey KG; Rains JC; Penzien DB; Nash JM; Nicholson RA
    Headache; 2005 May; 45(5):466-78. PubMed ID: 15953263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sequentially adjusted randomization to force balance in controlled trials with unknown prevalence of covariates: application to alcoholism research.
    Müller MJ; Scheurich A; Wetzel H; Szegedi A; Hautzinger M
    Alcohol Alcohol; 2005; 40(2):124-31. PubMed ID: 15642723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statistical considerations for the design and analysis of Phase III clinical trials in prostate cancer.
    Halabi S
    Urol Oncol; 2008; 26(3):300-7. PubMed ID: 18452825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudo cluster randomization performed well when used in practice.
    Melis RJ; Teerenstra S; Rikkert MG; Borm GF
    J Clin Epidemiol; 2008 Nov; 61(11):1169-75. PubMed ID: 18550331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The immediate and long-term effects of exercise and patient education on physical, functional, and quality-of-life outcome measures after single-level lumbar microdiscectomy: a randomized controlled trial protocol.
    Selkowitz DM; Kulig K; Poppert EM; Flanagan SP; Matthews ND; Beneck GJ; Popovich JM; Lona JR; Yamada KA; Burke WS; Ervin C; Powers CM;
    BMC Musculoskelet Disord; 2006 Aug; 7():70. PubMed ID: 16934143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and implementation of resuscitation research: special challenges and potential solutions.
    Nichol G; Huszti E
    Resuscitation; 2007 Jun; 73(3):337-46. PubMed ID: 17292525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient heterogeneity in clinical trials.
    Simon R
    Cancer Treat Rep; 1980; 64(2-3):405-10. PubMed ID: 7407777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studywise minimization: a treatment allocation method that improves balance among treatment groups and makes allocation unpredictable.
    Perry M; Faes M; Reelick MF; Olde Rikkert MG; Borm GF
    J Clin Epidemiol; 2010 Oct; 63(10):1118-22. PubMed ID: 20304606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The journal impact factor as a predictor of trial quality and outcomes: cohort study of hepatobiliary randomized clinical trials.
    Gluud LL; Sørensen TI; Gøtzsche PC; Gluud C
    Am J Gastroenterol; 2005 Nov; 100(11):2431-5. PubMed ID: 16279896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.